A double-blind placebo controlled trial of efamol marine on skin and joint symptoms of psoriatic arthritis

Rheumatology

Volumn 33, Issue 10, 1994, Pages 954-958

  Veale, D J ^a   Torley, H I ^b   Richards, I M ^b   O'dowd, A ^c   Fttzsimons, C ^d   Belch, J J F ^a   Sturrock, R D ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d ROYAL ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Arthritis; Essential fatty acid; Leukotrienes; Prostaglandins; Psoriasis

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; EFAMOL MARINE; FISH OIL; LEUKOTRIENE B4; NONSTEROID ANTIINFLAMMATORY AGENT; PRIMROSE OIL; PROSTAGLANDIN; THROMBOXANE B2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTHROPATHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, PSORIATIC; DOUBLE-BLIND METHOD; FATTY ACIDS, ESSENTIAL; FEMALE; GAMMA-LINOLENIC ACID; HUMANS; LEUKOTRIENE B4; LINOLEIC ACIDS; MALE; MIDDLE AGED; NEUTROPHILS; PLANT OILS; PROSTAGLANDINS; PSORIASIS; SEVERITY OF ILLNESS INDEX; THROMBOXANE B2;

EID: 0028134682     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/33.10.954     Document Type: Article

References (18)

1. Espinoza LR. Psoriatic arthritis: further epidemiological and genetic considerations. In: Gerber LH, Espinoza LR, eds. Psoriatic arthritis. Orlando: Grune and Stratton; 1985: 9–32.
2. Veale DJ, Rogers S, FitzGerald O. Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 1994;33:133–8.
3. Grabbe J, Czarnetzki BM, Rosenbach T, Merdin M. Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol 1984;82:477–9.
4. Kronmann N, Green A. Epidemiological studies in the Upernavik district, Greenland: incidence of some chronic diseases 1950–1974. Acta Med Scand 1980;208:401–6.
5. Zibek VA, Cohen KA, Charles EN et al. Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids. Modulation of clinical course of psoriatic subjects. Arch Derm 1986;122:1277–81.
6. Bittener SB, Hicker WFG, Cartwright I, Bleehen SS. A double-blind, randomised, placebo-controlled trial of fish oil m psoriasis. Lancet 1988;i:378–80.
7. Lau C, Morley K, McMahon H, Belch JJF. Maxepa reduces non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis. Br J Rheumatol 1993;32:982–9.
8. Kremer JM, Bigavoette J, Michalek AV et al. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985;i:184–7.
9. Lee TH, Hoover RL, Williams JD et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217–24.
10. 4production from white cells of patients with rheumatoid arthritis. Scand J Rheum 1989;18:213–9.
11. Maurice DL, Allen BR, Berkley AS, Lockbill SR, Stammers J, Bather PC. The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol 1987;iii:599–606.
12. Kremer JM, Jubiz W, Michalek A et al. Fish oil fatty acid supplementation in active rheumatoid arthritis. Ann Int Med 1987;106:497–503.
13. Belch JJF. The role of leukotrienes as mediators of inflammation. In: Moll JMH, Sturrock RD, eds. Recent advances in rheumatology. London: Churchill Livingston, 1986: 37–51.
14. 4Lancet 1982;ii:762–3.
15. 4J Invest Dermatol 1984;82:202.
16. Ellis CN, Fallon JSD, Heezen JL, Voorhees JR. Topical indomethacin exacerbates lesions of psoriasis. J Invest Dermatol 1983;80:362.
17. Belch JJF, Ansell D, Madhok R, O’Dowd A, Sturrock RD. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 1988;47:96–104.
18. Laurent MR, Panayi GS, Shepherd P. Circulating immune complexes, serum immunoglobulins and acute phase proteins in psoriasis and psoriatic arthritis. Ann Rheum Dis 1981;40:66–9.